A Phase II Randomized, Observer-Blind, Multi-Center, Controlled Study of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

Trial Profile

A Phase II Randomized, Observer-Blind, Multi-Center, Controlled Study of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jan 2018

At a glance

  • Drugs Streptococcal B vaccine (Primary)
  • Indications Streptococcal infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 25 Jan 2018 Results exploratory study assessing reactogenicity and immune response induced by the streptococcal B vaccine in healthy pregnant women, were published in the Journal of Infection.
    • 01 Feb 2016 Results published in the Obstetrics and Gynecology
    • 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top